Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

CNBX Pharmaceuticals (CNBX) Gross Profit (2016 - 2024)

CNBX Pharmaceuticals (CNBX) has disclosed Gross Profit for 6 consecutive years, with $34417.0 as the latest value for Q1 2024.

  • For the quarter ending Q1 2024, Gross Profit changed N/A year-over-year to $34417.0, compared with a TTM value of $26866.0 through Feb 2025, up 496.62%, and an annual FY2025 reading of -$40445.0, down 152.87% over the prior year.
  • Gross Profit was $34417.0 for Q1 2024 at CNBX Pharmaceuticals, up from -$7551.0 in the prior quarter.
  • Across five years, Gross Profit topped out at $34417.0 in Q1 2024 and bottomed at -$7551.0 in Q4 2020.